Live Status Check

NCT06947083 Recruiting Status

Real-time enrollment status for this myeloma clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 2:52 PM UTC

NCT06947083 Status Summary

NCT NumberNCT06947083
Recruiting StatusRecruiting
ConditionMyeloma
PhaseClinical Trial
Target Enrollment39 participants
Active Locations1 sites in the US
SponsorH. Lee Moffitt Cancer Center and Research Institute
Last Updated on CT.govDecember 3, 2025 (Dec 3, 2025)

About NCT06947083 Enrollment Status

As of July 13, 2026: Clinical trial NCT06947083 is currently recruiting participants. This clinical trial study for myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by H. Lee Moffitt Cancer Center and Research Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06947083

Is NCT06947083 still recruiting?

Yes, NCT06947083 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06947083 recruiting?

This trial is recruiting at 1 location in the United States. View all available locations on the full study page.

How do I enroll in NCT06947083?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06947083 status last updated?

The official ClinicalTrials.gov record for NCT06947083 was last updated Dec 3, 2025 (December 3, 2025). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial